Test That May Expedite Patient Therapy Receives FDA Approval

Posted on

The Food and Drug Administration has given its approval to a test that is supposed to allow for more expedient testing procedures that should enable doctors to treat patients suffering from illnesses related to yeast or bacteria more quickly.  The new mass spectrometer system, which goes by the name VITEK MS, is purported to be able to identify harmful microorganisms within a day, which is far shorter than the five days that comparable tests usually take.  There are 192 tests that can be carried out with the product and 193 microorganisms that can be identified, and when the culprit is pegged, a patient enduring a serious illness may be able to receive therapy faster than they otherwise would with other tests.

For more about this test, click here.